港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

海西新药

201.000

-3.200-1.57%

成交量：10.50万

成交额：2,102.09万

市值：158.20亿

市盈率：67.55

高：204.200

开：201.000

低：196.600

收：204.200

52周最高：302.400

52周最低：97.500

股本：7,870.73万

香港流通股本：7,870.73万

量比：0.37

换手率：0.13%

股息：- -

股息率：- -

每股收益(LYR):2.976

净资产收益率：16.58%

总资产收益率：9.23%

市净率：8.51

市盈率(LYR):67.55

市销率: 23.28

数据加载中...

总览公司新闻资讯公告

财报前瞻｜海西新药本季度营收预测缺失，机构观点待跟进

【券商聚焦】国联民生首予海西新药（02637）推荐评级指HXP056具大单品潜力

港股创新药概念股盘初活跃，金斯瑞生物科技、海西新药涨超8%

老虎资讯综合

港股异动 | 海西新药(02637.HK)早盘涨超12% 创新药HX9428获FDA授予快速通道资格

智通港股早知道 | 宇树机器人累计生产下线1.8万台石油天然气“十五五”规划出炉

海西新药(02637)：口服候选药HX9428获美国FDA快速通道资格

海西新药(02637)：HX9428用于治疗新生血管性年龄相关性黄斑变性获美国FDA授予快速通道资格

海西新药Hx9428获美国FDA快速通道认定，瞄准新生血管性年龄相关性黄斑变性治疗

医药股局部走强海西新药（02637）上涨8.98% 机构指AI制药进展率先带动生命科学上游需求

港股创新药概念股盘中走强，和黄医药涨超7%，药明生物、金斯瑞生物科技涨超5%

老虎资讯综合

海西新药（02637）拟于8月28日召开董事会审议中期业绩及分红事宜

海西新药（02637）发布补充公告　详释更换外聘核数师原因及后续审计安排

《股市简讯》中国海西新药大涨14.5%创近四周新高，眼科药物美国临床试验获批

海西新药盘中涨超14% HX9428在美获批启动II期临床

港股异动 | 海西新药(02637.HK)早盘涨超14% HX9428在美获批启动II期临床同时在中国启动临床试验

海西新药（02637.HK）HX9428获美FDA批准开展II期临床并在中国启动对照试验

海西新药(02637)：HX9428治疗新生血管性年龄相关性黄斑变性获美国FDA IND批准启动II期临床试验同时在中国启动第二项采用阳性对照的II期临床试验

海西新药：美国FDA批准Hx9428用于治疗新生血管性年龄相关性黄斑变性的临床试验申请

海西新药（02637）2026年首场临时股东会通过更换核数师及补选执行董事

海西新药（02637）公布董事会及四大专门委员会最新构成

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/02637/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"海西新药","latestPrice":201,"timestamp":1787299687040,"preClose":204.2,"halted":0,"volume":105000,"delay":0,"changeRate":-0.015670910871694362,"floatShares":78707270,"shares":78707270,"eps":2.975563205231751,"marketStatus":"休市中","change":-3.2,"latestTime":"08-21 16:08:07","open":201,"high":204.2,"low":196.6,"amount":21020868,"amplitude":0.037218,"askPrice":206.8,"askSize":500,"bidPrice":201,"bidSize":550,"shortable":3,"etf":0,"ttmEps":2.9055499533439453,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":204.2,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.3655861566108926,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","floatShares":78707270,"roa":"9.23%","roe":"16.58%","lyrEps":2.975563,"volumeRatio":0.3655861566108926,"shares":78707270,"dividePrice":0,"high":204.2,"amplitude":0.037218,"preClose":204.2,"low":196.6,"week52Low":97.5,"pbRate":"8.51","psRate":"23.28","week52High":302.4,"institutionHeld":0,"latestPrice":201,"committee":0.047619,"eps":2.975563205231751,"divideRate":0,"volume":105000,"delay":0,"ttmEps":2.9055499533439453,"open":201,"prevYearClose":136,"prevWeekClose":204.8,"prevMonthClose":171,"prevQuarterClose":180,"fiveDayClose":204.8,"twentyDayClose":183.6,"sixtyDayClose":225.6,"earningDate":1787846400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02637\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-30","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02637\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1781107200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02637","date":"2026-08-21","current":69.177954,"percent":0.731707,"low":41.43616,"twenty":68.323237,"median":72.054899,"eighty":79.190679,"high":108.687128,"avg":73.776853,"sd":9.167145,"marketCap":15820161270},"quantilePoints":[{"date":"2025-10-16","current":41.43616,"twenty":41.43616,"median":41.43616,"eighty":41.43616,"marketCap":6150186077},{"date":"2025-10-24","current":58.044665,"twenty":53.788314,"median":54.742854,"eighty":58.044665,"marketCap":8618446065},{"date":"2025-10-31","current":63.409996,"twenty":54.11413,"median":58.177187,"eighty":60.582738,"marketCap":9429130946},{"date":"2025-11-07","current":65.038519,"twenty":55.071217,"median":59.875924,"eighty":63.533346,"marketCap":9665252756},{"date":"2025-11-14","current":69.713569,"twenty":57.493757,"median":61.562796,"eighty":68.778725,"marketCap":10389359640},{"date":"2025-11-21","current":66.575785,"twenty":58.2567,"median":64.026746,"eighty":69.208194,"marketCap":9917116020},{"date":"2025-11-28","current":68.072175,"twenty":59.478322,"median":65.807152,"eighty":68.767812,"marketCap":10176850011},{"date":"2025-12-05","current":68.42835,"twenty":59.854834,"median":66.893861,"eighty":68.767812,"marketCap":10247686554},{"date":"2025-12-12","current":69.403659,"twenty":60.326406,"median":67.279459,"eighty":69.361692,"marketCap":10412971821},{"date":"2025-12-19","current":69.502155,"twenty":61.237436,"median":67.861589,"eighty":69.423358,"marketCap":10452325456},{"date":"2025-12-24","current":72.521094,"twenty":61.537644,"median":68.055113,"eighty":69.462757,"marketCap":10940310530},{"date":"2026-01-02","current":68.547,"twenty":62.032842,"median":68.254334,"eighty":69.697511,"marketCap":10381488913},{"date":"2026-01-09","current":76.256401,"twenty":63.533346,"median":68.54394,"eighty":70.33117,"marketCap":11577839417},{"date":"2026-01-16","current":83.450154,"twenty":64.030428,"median":68.594109,"eighty":71.180851,"marketCap":12711224105},{"date":"2026-01-23","current":75.203122,"twenty":64.243828,"median":68.851274,"eighty":73.407226,"marketCap":11444037058},{"date":"2026-01-30","current":72.029156,"twenty":65.345972,"median":69.26967,"eighty":73.580372,"marketCap":11011147073},{"date":"2026-02-06","current":69.741329,"twenty":66.631937,"median":69.18814,"eighty":73.524909,"marketCap":10688447266},{"date":"2026-02-13","current":69.700471,"twenty":66.864009,"median":69.376262,"eighty":73.289662,"marketCap":10743542355},{"date":"2026-02-20","current":69.085102,"twenty":66.878935,"median":69.376262,"eighty":72.984771,"marketCap":10633352177},{"date":"2026-02-27","current":72.331605,"twenty":67.046254,"median":69.403659,"eighty":72.584608,"marketCap":11255139610},{"date":"2026-03-06","current":63.89376,"twenty":67.046254,"median":69.448144,"eighty":72.584608,"marketCap":9862020931},{"date":"2026-03-13","current":75.4784,"twenty":67.193436,"median":69.633279,"eighty":73.562991,"marketCap":11703771049},{"date":"2026-03-20","current":69.956787,"twenty":67.26348,"median":69.715081,"eighty":73.483508,"marketCap":10806508171},{"date":"2026-03-27","current":78.768036,"twenty":67.31702,"median":69.741329,"eighty":73.616705,"marketCap":12136661034},{"date":"2026-04-02","current":69.050489,"twenty":67.448055,"median":69.756887,"eighty":73.953025,"marketCap":13907574609},{"date":"2026-04-10","current":75.734842,"twenty":67.617502,"median":69.89051,"eighty":74.51958,"marketCap":15371529831},{"date":"2026-04-17","current":75.664292,"twenty":67.861589,"median":70.029272,"eighty":74.51958,"marketCap":15363659104},{"date":"2026-04-24","current":92.094347,"twenty":68.038051,"median":70.361759,"eighty":74.892793,"marketCap":18700847352},{"date":"2026-04-30","current":101.138303,"twenty":68.06535,"median":70.518529,"eighty":75.515578,"marketCap":20542597470},{"date":"2026-05-08","current":91.134409,"twenty":68.133872,"median":70.614497,"eighty":76.472636,"marketCap":18574915720},{"date":"2026-05-15","current":84.578883,"twenty":68.178204,"median":70.813553,"eighty":78.193464,"marketCap":17284116492},{"date":"2026-05-22","current":93.496946,"twenty":68.295676,"median":71.108793,"eighty":80.407586,"marketCap":19062900794},{"date":"2026-05-29","current":86.09458,"twenty":68.386305,"median":71.340959,"eighty":80.936301,"marketCap":17614687026},{"date":"2026-06-05","current":72.717092,"twenty":68.497704,"median":72.103769,"eighty":80.766638,"marketCap":14899286211},{"date":"2026-06-12","current":67.961351,"twenty":68.497704,"median":71.340959,"eighty":80.580489,"marketCap":13915445336},{"date":"2026-06-18","current":66.149737,"twenty":68.365282,"median":71.108793,"eighty":80.547429,"marketCap":13577004075},{"date":"2026-06-26","current":64.123676,"twenty":68.103023,"median":70.813553,"eighty":80.470686,"marketCap":13096889728},{"date":"2026-07-03","current":76.78307,"twenty":68.156523,"median":70.813553,"eighty":80.277662,"marketCap":15694229638},{"date":"2026-07-10","current":79.190679,"twenty":68.212992,"median":71.108793,"eighty":80.277662,"marketCap":16166473258},{"date":"2026-07-17","current":71.84101,"twenty":68.34426,"median":71.590985,"eighty":79.86919,"marketCap":14718259490},{"date":"2026-07-24","current":70.518964,"twenty":68.451468,"median":71.287767,"eighty":79.796901,"marketCap":14450654772},{"date":"2026-07-31","current":65.554893,"twenty":68.149296,"median":70.906272,"eighty":79.747346,"marketCap":13458943170},{"date":"2026-08-07","current":75.261161,"twenty":68.149296,"median":71.19828,"eighty":79.190679,"marketCap":15481720009},{"date":"2026-08-14","current":78.261297,"twenty":68.185431,"median":71.340959,"eighty":78.768036,"marketCap":16119248896},{"date":"2026-08-21","current":76.639812,"twenty":68.323237,"median":72.054899,"eighty":79.190679,"marketCap":15820161270}],"updateTime":1787449971430},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02637\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1140072246","title":"财报前瞻｜海西新药本季度营收预测缺失，机构观点待跟进","url":"https://stock-news.laohu8.com/highlight/detail?id=1140072246","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1140072246?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 10:38","pubTimestamp":1787279910,"startTime":"0","endTime":"0","summary":"海西新药将于2026年08月28日披露最新季度财报，当前公开信息对关键指标缺乏一致预测，市场关注主营业务韧性与盈利质量变化。由于缺乏可获取的市场一致预期与公司指引，当前未能找到关于本季度营收、毛利率、净利润或净利率、调整后每股收益的具体预测及同比数据。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜海西新药本季度营收预测缺失，机构观点待跟进","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660741707","title":"【券商聚焦】国联民生首予海西新药（02637）推荐评级 指HXP056具大单品潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2660741707","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660741707?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 14:30","pubTimestamp":1787121015,"startTime":"0","endTime":"0","summary":"仿制药业务提供稳定现金流与商业化底盘，而HXP056具备“超级大单品”潜力，是打开中长期估值上限的核心引擎。研报重点指出，HXP056是FIC药物，享有定价权和市场独占期，存在真实临床需求，市场天花板足够大。基于DCF估值，研报认为海西新药合理股权价值为230亿港元，对应目标价294港元。首次覆盖，给予“推荐”评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988698","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01456","KCE","601456","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125396547","title":"港股创新药概念股盘初活跃，金斯瑞生物科技、海西新药涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125396547","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125396547?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 09:35","pubTimestamp":1787016939,"startTime":"0","endTime":"0","summary":"8月18日，港股创新药概念股盘初活跃，$金斯瑞生物科技(01548)$、$海西新药(02637)$涨超8%，$药明生物(02269)$、$云顶新耀(01952)$、$百济神州(06160)$、$药明合联(02268)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU2488822045.USD","LU0320764599.SGD","LU0039217434.USD","HK0000306685.HKD","LU0819121731.USD","LU0348735423.USD","IE00B0JY6N72.USD","SG9999002463.SGD","VXUS","LU0823426308.USD","BK4139","LU0359201612.USD","LU0516422952.EUR","HK0000306701.USD","LU0456827905.SGD","BK1610","LU0456846285.SGD","LU0979878070.USD","KURE","02268","LU0823426480.USD","LU1720050803.USD","BK1521","SG9999014674.SGD","BK4588","LU0029874061.USD","LU0140636845.USD","LU1242518857.USD","02269","LU0516423091.SGD","LU0348825331.USD","LU1688375341.USD","LU0516422366.SGD","KCAI","BK1583","LU0307460666.USD","LU0181495838.USD","LU0516423174.USD","LU0588546209.SGD","LU3063872942.SGD","LU0327786744.USD","ONC","LU0043850808.USD","LU2039709279.SGD","LU1242518931.SGD","LU0572944931.SGD","LU0516422440.USD","BK1161","LU0359202008.SGD","LU0051755006.USD","BK1576","BK1191","BK1589","BK4585","HK0000320223.HKD","LU0417516738.SGD","LU1880383366.USD","SG9999002562.SGD","01548","01952","02637","LU0417516902.SGD","LU0326950275.SGD","BK4526","LU0052750758.USD","BK1574","HK0000320264.USD","LU1794554557.SGD","LU0856984785.SGD","LU0128526141.USD","LU0708995583.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660045569","title":"港股异动 | 海西新药(02637.HK)早盘涨超12% 创新药HX9428获FDA授予快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2660045569","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660045569?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 09:33","pubTimestamp":1787016811,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","02637","BK1574","06978","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660302214","title":"智通港股早知道 | 宇树机器人累计生产下线1.8万台 石油天然气“十五五”规划出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2660302214","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660302214?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 07:13","pubTimestamp":1787008422,"startTime":"0","endTime":"0","summary":"人形机器人量产显著提速 宇树IPO有望带动本体厂商估值重塑8月12日，宇树科技宣布旗下仿生双足人形机器人累计生产下线约1.8万台，不含其他类人形及轮式底盘产品。国家发展改革委、国家能源局印发《石油天然气发展“十五五”规划》智通财经APP获悉，8月17日，国家发展改革委、国家能源局印发《石油天然气发展“十五五”规划》。加强石油供需情况监测。事件未造成人员伤亡及设备损失。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BNO","BK1191","06990","OIH","XOP","XES","KOLD","ERX","BK1183","PXE","USL","VXUS","02637","VDE","XLE","OILK","BK4585","GUSH","DUG","PXJ","PBOT","OILT","NGmain","UGAZ","MNGmain","UNG","02285","KCAI","BOIL","DIG","00179","WTIU","DRLL","FTXN","02432","06613","IXC","ROBO","KOMP","USOI","USE","DBC","159019","FCG","IEO","DBE","DGAZ","DRIP","OILU","QGmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193242998","title":"海西新药(02637)：口服候选药HX9428获美国FDA快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1193242998","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193242998?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 19:51","pubTimestamp":1786967491,"startTime":"0","endTime":"0","summary":"2026年8月17日，海西新药全称福建海西新药创制股份有限公司发布自愿公告称，其自主研发的创新药项目HXP056之候选分子HX9428已获美国食品药品监督管理局授予快速通道资格，适应症为新生血管性年龄相关性黄斑变性。\\n\\n根据公告，FTD将使HX9428在临床开发全流程可与FDA开展高频、及时的沟通交流，并具备后续申请优先审评、加速批准及滚动审评等政策支持，或可加速全球临床开发进程。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482197","title":"海西新药(02637)：HX9428用于治疗新生血管性年龄相关性黄斑变性获美国FDA授予快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482197","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482197?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 19:50","pubTimestamp":1786967418,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海西新药 发布公告，公司自主研发的创新药项目HXP056的候选药物分子HX9428，获美国食品药品监督管理局授予快速通道资格，用于开发治疗新生血管性年龄相关性黄斑变性。HX9428是海西新药自主研发的全新口服小分子创新药物，拟用于治疗nAMD。海外研发同步落地，HX9428已获FDA批准在美国开展nAMD适应症II期临床试验，公司正全力推进美国临床开发布局，以期早日惠及全球患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4588","LABU","02637","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144435453","title":"海西新药Hx9428获美国FDA快速通道认定，瞄准新生血管性年龄相关性黄斑变性治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1144435453","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144435453?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 19:48","pubTimestamp":1786967309,"startTime":"0","endTime":"0","summary":"福建海西新药股份有限公司传来重磅消息——其在研药物Hx9428已正式获得美国食品药品监督管理局（FDA）授予的快速通道资格认定，适应症指向新生血管性年龄相关性黄斑变性这一棘手的眼科疾病。这一认定不仅意味着该药物有望加速研发进程，更凸显了海西新药在创新药赛道上的前瞻布局与研发实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660102783","title":"医药股局部走强 海西新药（02637）上涨8.98% 机构指AI制药进展率先带动生命科学上游需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2660102783","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660102783?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 13:50","pubTimestamp":1786945800,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股局部走强，海西新药 上涨8.98%、凯莱英上涨7.95%、英派药业-B上涨7.71%、昭衍新药上涨6.86%、金斯瑞生物科技上涨6.83%、现代中药集团上涨5.95%东吴证券表示，AI制药进展率先带动生命科学上游需求。上游需求端，基因合成、蛋白表达与纯化、体外验证、模式动物等环节均因AI候选分子爆发而系统性受益，其中公司预计TwistAI相关订单预计从2500万美元跃升至1亿美元量级，金斯瑞生物科技一体化蛋白表达服务迎来高速增长。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988436","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","BK1161","BK1576","02637","ARTY","BK1141","BK1515","HK0000306701.USD","09939","BK1191","BK1574","07630","01643","BK1583","06127","HK0000320264.USD","HK0000320223.HKD","HK0000306685.HKD","AIPO","BK1606","06821","CHAT","01477","01548","QTOC","159938","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173380078","title":"港股创新药概念股盘中走强，和黄医药涨超7%，药明生物、金斯瑞生物科技涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173380078","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173380078?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 10:08","pubTimestamp":1786932515,"startTime":"0","endTime":"0","summary":"8月17日，港股创新药概念股盘中走强，$和黄医药(00013)$涨超7%，$药明生物(02269)$、$海西新药(02637)$、$金斯瑞生物科技(01548)$涨超5%，$药明康德(02359)$、$药明合联(02268)$涨超4%，$信达生物(01801)$、$石药集团(01093)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1141","LU1226288253.USD","LU0051755006.USD","LU0043850808.USD","LU0516422440.USD","HK0000165453.HKD","LU1794554557.SGD","SG9999002562.SGD","LU0516422952.EUR","LU0516422366.SGD","LU0819121731.USD","IBBQ","IE0008368742.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","HK0000306685.HKD","LU1951186391.HKD","LU0029874061.USD","LU0463099449.HKD","LU0314109678.HKD","LU0348735423.USD","LU0979878070.USD","LU0181495838.USD","BK1610","LU0326950275.SGD","IE00B543WZ88.USD","KURE","LU0348825331.USD","IE00B5MMRT66.SGD","LU1226288170.HKD","BK4007","LU1226287875.USD","LU1993786604.SGD","LU1813983027.USD","01801","LU3063872942.SGD","LU0359202008.SGD","HK0000320264.USD","LU0823426480.USD","LU2097828474.EUR","LU2045819591.USD","VXUS","BK1587","LU0315179316.USD","LU1188198961.HKD","LU0417516902.SGD","LU0140636845.USD","LU0128526141.USD","LU1880383366.USD","LU1242518857.USD","LU2488822045.USD","LNGR","LU0455707207.USD","BK4531","LU0588546209.SGD","LU1720050803.USD","LU1152091754.HKD","LU2125910500.SGD","LU2328871848.SGD","IE00BZ08YS42.EUR","BK1191","LU0456846285.SGD","LU0501845795.SGD","LU0320764599.SGD","BK4585","159992","SG9999014674.SGD","00013","LU1046422090.SGD","BK4588","IE00B031HY20.USD","LU0456827905.SGD","LU0572944931.SGD","LU0823426308.USD","MEDX","IE00B0JY6N72.USD","BK1589","01548","LU2097828631.EUR","LU1688375341.USD","LU0417516738.SGD","HK0000306701.USD","LU0039217434.USD","LU2097828557.USD","01093","BK1161","LU0067412154.USD","LU0856984785.SGD","06978","IE0008369823.USD","HK0000320223.HKD","LU1008478684.HKD","LU0307460666.USD","LU1152091168.USD","LU1960683339.HKD","02637","LU1328277881.USD","LU0359201612.USD","LU0327786744.USD","SG9999002463.SGD","LU0469268626.HKD","LU0348767384.USD","LU0502904849.HKD","KCAI","LU0708995583.HKD","LU2242644610.SGD","BK1521","LU0072913022.USD","LU0244354667.USD","LU2039709279.SGD","BK1515","LU2097828714.EUR","LU0880133367.SGD","BK1588","BK1574","IE00BZ08YT58.USD","LU0516423091.SGD","BK1576","LU0516423174.USD","LU0052750758.USD","LU2097828805.USD","SG9999004220.SGD","LU1969619763.USD","LU1226287529.USD","02359","02269","LU0348766576.USD","LU1242518931.SGD","LU1807302812.USD","HCM","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126530849","title":"海西新药（02637）拟于8月28日召开董事会审议中期业绩及分红事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1126530849","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126530849?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 17:46","pubTimestamp":1786527969,"startTime":"0","endTime":"0","summary":"海西新药（02637）8月12日在港交所公告称，公司董事会将于2026年8月28日（星期五）召开会议，主要议程包括：一、审议及批准集团截至2026年6月30日止六个月的中期业绩并发布；二、讨论及建议派付中期股息（如有）；三、处理其他相关事项。\n公告显示，董事会目前由九名董事组成，包括五名执行董事康心汕、Feng Yan、Chen Guangming、李俊青及陈廷泽；一名非执行董事许冬；以及三名独立非执行董事王珊珊、蒲美婷和林斌。\n公司执行董事、董事长兼总经理康心汕代表董事会签署了本次公告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146170998","title":"海西新药（02637）发布补充公告　详释更换外聘核数师原因及后续审计安排","url":"https://stock-news.laohu8.com/highlight/detail?id=1146170998","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146170998?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 19:16","pubTimestamp":1786446985,"startTime":"0","endTime":"0","summary":"福建海西新药创制股份有限公司8月11日发布有关建议更换外聘核数师的补充公告，披露具体时间轴、审计师遴选过程及后续审计计划，并重申与原审计师德勤—关黄陈方会计师行不存在任何意见分歧。公司强调，更换外聘核数师乃应对持续出现的外部监管及融资需求而作出的审慎决定，不涉及对德勤审计质量的任何异议。董事会与审核委员会认为，此举符合公司及股东整体利益，可确保2026年度审计工作在中国准则下顺利进行并避免重复审计成本。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657599078","title":"《股市简讯》中国海西新药大涨14.5%创近四周新高，眼科药物美国临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2657599078","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657599078?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 10:29","pubTimestamp":1785896998,"startTime":"0","endTime":"0","summary":"《股市简讯》中国海西新药大涨14.5%创近四周新高，眼科药物美国临床试验获批* 中国海西新药2637.HK周三早盘劲升14.5%，创7月10日以来新高。同时，公司已于中国启动HX9428治疗nAMD的第二项II期临床研究，头对头对比评估HX9428与临床标准疗法药物阿柏西普的有效性及安全性。* 海西新药今年迄今劲涨45.4%，同期恒生指数.HSI上扬1.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4T44207M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657591850","title":"海西新药盘中涨超14% HX9428在美获批启动II期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2657591850","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657591850?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 10:22","pubTimestamp":1785896520,"startTime":"0","endTime":"0","summary":"模拟交易客户端海西新药早盘一度涨超14%，截至发稿，股价上涨5.42%，现报196.40港元，成交额2128.27万港元。海西新药发布公告，公司自主研发的创新药候选分子HX9428治疗新生血管性年龄相关性黄斑变性的美国临床试验申请已获美国食品药品监督管理局批准，正式启动II期临床试验；同时，公司在中国启动第二项采用阳性对照的II期临床试验，计划入组60例患者。HX9428尚未获批上市，安全性和有效性需进一步验证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-05/doc-inimfmyp5317024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657459963","title":"港股异动 | 海西新药(02637.HK)早盘涨超14% HX9428在美获批启动II期临床 同时在中国启动临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2657459963","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657459963?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 09:44","pubTimestamp":1785894295,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168351594","title":"海西新药（02637.HK）HX9428获美FDA批准开展II期临床 并在中国启动对照试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1168351594","media":"公告速递","labels":["productRelease","policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168351594?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 17:16","pubTimestamp":1785834973,"startTime":"0","endTime":"0","summary":"2026年8月4日，福建海西新药创制股份有限公司发布自愿公告称，公司自主研发的创新药候选分子HX9428用于治疗新生血管性年龄相关性黄斑变性的临床试验申请已获美国食品药品监督管理局批准，许可启动一项II期临床试验。\\n\\n截至公告披露日，HX9428尚未获得任何国家或地区药品监管机构的上市批准，其安全性与有效性仍需通过进一步临床研究验证。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656460539","title":"海西新药(02637)：HX9428治疗新生血管性年龄相关性黄斑变性获美国FDA IND批准启动II期临床试验 同时在中国启动第二项采用阳性对照的II期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2656460539","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656460539?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 17:15","pubTimestamp":1785834956,"startTime":"0","endTime":"0","summary":"此次获批的IND涵盖一项II期临床试验方案，旨在评估HX9428不同口服剂量在美国 nAMD患者中的有效性及安全性。该研究为集团在HX9428既往I 期及II期剂量扩展研究的基础上，进一步启动的一项随机、阳性对照的II期临床研究。本次美国FDAII期临床试验获批、中国标准疗法对照II期临床试验启动，标志着 HX9428全球临床开发进程取得重要进展，为全面验证HX9428在nAMD治疗中的临床价值奠定坚实基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","PSYK","IBBQ","02637","MDTX","IND","BMED","IBBJ","BK4588","BK1191","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151906205","title":"海西新药：美国FDA批准Hx9428用于治疗新生血管性年龄相关性黄斑变性的临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1151906205","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151906205?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 17:13","pubTimestamp":1785834789,"startTime":"0","endTime":"0","summary":"海西新药宣布，其研发的Hx9428药物已获得美国食品药品监督管理局（FDA）批准，可开展针对新生血管性年龄相关性黄斑变性（nAMD）的临床试验申请（IND）。这一进展标志着该公司在眼科疾病治疗领域取得重要突破，为后续临床开发奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104460756","title":"海西新药（02637）2026年首场临时股东会通过更换核数师及补选执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1104460756","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104460756?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 16:57","pubTimestamp":1785833851,"startTime":"0","endTime":"0","summary":"福建海西新药创制股份有限公司于2026年8月4日在福建福州召开2026年第一次临时股东大会。会议以一股一票方式对全部两项普通决议案进行表决，具体结果如下：。截至会议当天，公司已发行股份总数为78,707,270股；具备出席并投票权的股份同为78,707,270股。董事会人事方面，王忻琨先生于会议结束后退任董事职务；陈廷澤先生获股东大会选任为执行董事，任期自股东大会结束之日起至第二届董事会任期届满为止。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118532919","title":"海西新药（02637）公布董事会及四大专门委员会最新构成","url":"https://stock-news.laohu8.com/highlight/detail?id=1118532919","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118532919?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 16:57","pubTimestamp":1785833829,"startTime":"0","endTime":"0","summary":"2026年8月4日，福建海西新药创制股份有限公司发布公告，更新公司董事会及其下设四个专门委员会的人员名单。公告称，新一届董事会及其专门委员会的组成将自公布之日起生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":104,"code":"91000000","status":"200"}]}}